Characterization of polarized expression of point- or deletion-mutated human BCRP/ABCG2 in LLC-PK1 cells
- PMID: 15835752
- DOI: 10.1007/s11095-004-1884-9
Characterization of polarized expression of point- or deletion-mutated human BCRP/ABCG2 in LLC-PK1 cells
Abstract
Purpose: In polarized cells, such as hepatocytes and intestinal epithelial cells, transporters are localized on the apical or basolateral membranes and play important roles in the vectorial transport of their substrates. In the current study, we have aimed to clarify the mechanism for the cellular sorting of human breast cancer resistance protein (BCRP/ABCG2), which is expressed on the apical membrane of many tissues and functions as an efflux transporter.
Methods: After the expression vector, including wild type or mutants of human BCRP cDNA, was transfected into LLC-PK1 cells, immunohistochemical staining and Western blot analyses were performed to characterize the cellular localization and the status of BCRP, respectively.
Results: The transfected cDNA product of wild-type BCRP was expressed on the apical membrane in LLC-PK1 cells. Glycosylation consensus sequences-disrupted mutants showed the apical localization as the wild type, whereas the apical-selective expression disappeared when disulfide bonds could not be formed. Furthermore, examination of the localization of deletion mutants of human BCRP emphasized the importance of some peptide sequences. The region between the N-terminal and ATP-binding cassette and proximal C-terminal region, both of which are well conserved in various animal species, were found to be significant for proper localization.
Conclusions: These results suggest that, although the presence of N-glycan does not affect the localization of BCRP, disulfide bonds and some peptide sequences in both the N- and C-terminals are necessary for the apical expression of BCRP.
Similar articles
-
Functional analysis of SNPs variants of BCRP/ABCG2.Pharm Res. 2004 Oct;21(10):1895-903. doi: 10.1023/b:pham.0000045245.21637.d4. Pharm Res. 2004. PMID: 15553238
-
Single nucleotide polymorphisms result in impaired membrane localization and reduced atpase activity in multidrug transporter ABCG2.Int J Cancer. 2004 Mar 20;109(2):238-46. doi: 10.1002/ijc.11669. Int J Cancer. 2004. PMID: 14750175
-
The Impact of Endogenous Breast Cancer Resistance Protein on Human P-Glycoprotein-Mediated Transport Assays Using LLC-PK1 Cells Transfected With Human P-Glycoprotein.J Pharm Sci. 2019 Mar;108(3):1085-1089. doi: 10.1016/j.xphs.2018.10.012. Epub 2018 Oct 16. J Pharm Sci. 2019. PMID: 30339864
-
In vitro and in vivo evidence for the importance of breast cancer resistance protein transporters (BCRP/MXR/ABCP/ABCG2).Handb Exp Pharmacol. 2011;(201):325-71. doi: 10.1007/978-3-642-14541-4_9. Handb Exp Pharmacol. 2011. PMID: 21103975 Review.
-
Multidrug resistance mediated by the breast cancer resistance protein BCRP (ABCG2).Oncogene. 2003 Oct 20;22(47):7340-58. doi: 10.1038/sj.onc.1206938. Oncogene. 2003. PMID: 14576842 Review.
Cited by
-
Differences in the expression of endogenous efflux transporters in MDR1-transfected versus wildtype cell lines affect P-glycoprotein mediated drug transport.Br J Pharmacol. 2010 Jul;160(6):1453-63. doi: 10.1111/j.1476-5381.2010.00801.x. Br J Pharmacol. 2010. PMID: 20590635 Free PMC article.
-
Fructose Intake, Serum Uric Acid, and Cardiometabolic Disorders: A Critical Review.Nutrients. 2017 Apr 18;9(4):395. doi: 10.3390/nu9040395. Nutrients. 2017. PMID: 28420204 Free PMC article. Review.
-
Identification of Two Dysfunctional Variants in the ABCG2 Urate Transporter Associated with Pediatric-Onset of Familial Hyperuricemia and Early-Onset Gout.Int J Mol Sci. 2021 Feb 16;22(4):1935. doi: 10.3390/ijms22041935. Int J Mol Sci. 2021. PMID: 33669292 Free PMC article.
-
Exercise serum regulates uric acid transporters in normal rat kidney cells.Sci Rep. 2022 Oct 27;12(1):18086. doi: 10.1038/s41598-022-22570-w. Sci Rep. 2022. PMID: 36302802 Free PMC article.
-
Paliperidone, a relatively novel atypical antipsychotic drug, is a substrate for breast cancer resistance protein.Exp Ther Med. 2018 Dec;16(6):5410-5416. doi: 10.3892/etm.2018.6847. Epub 2018 Oct 11. Exp Ther Med. 2018. PMID: 30542502 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources